Pfizer officially opened a new biotechnology packaging facility in Hampshire, UK, on October 15, with a ceremony attended by UK …

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …

The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …
Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
Pfizer is to purchase King Pharmaceuticals for $3.6 billion to significantly strengthen its pain portfolio and continue to diversify its …
Pfizer is reviewing options for its drug delivery systems business Capsugel, including a possible sale of the unit. Pfizer has …

Pfizer is campaigning for better care for people suffering from chronic pain and has turned to social media to galvanise …
Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …
A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …
Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …
Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …

Pfizer UK has turned to social media to help raise awareness of its online Man MOT male health clinic and …